INTELLIGENT BIO SOLUTIONS IN (INBS)
US36151G6008 - Common Stock
| TTM (2024-9-30) | 2024 (2024-6-30) | 2023 (2023-6-30) | 2022 (2022-6-30) | 2021 (2021-6-30) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -10.45M | -10.19M | -10.66M | -8.33M | -7.06M | |||
| Depreciation Amortization | 968.38K | 974.36K | 814.50K | N/A | N/A | |||
| Change In Working Capital | -1.59M | -701.93K | 78.90K | 2.44M | -4.94M | |||
| Interest Paid | N/A | N/A | N/A | 0.00 | 185.30K | |||
| Other non cash items | 423.77K | 346.94K | 2.39M | 2.54M | 704.40K | |||
| OPERATING CASH FLOW | -10.65M | -9.57M | -7.38M | -3.36M | -11.30M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | N/A | -5.37K | N/A | N/A | N/A | |||
| Other Investing Activity | N/A | -216.06K | -694.10K | -880.20K | N/A | |||
| INVESTING CASH FLOW | N/A | -221.43K | -694.10K | -880.20K | N/A | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | N/A | N/A | N/A | N/A | |||
| Stock Issued/Repurchased | N/A | 5.44M | 2.76M | 0.00 | 25.41M | |||
| Other Financing Activity | N/A | 9.12M | -1.33M | 0.00 | -2.00M | |||
| FINANCING CASH FLOW | N/A | 14.56M | 1.44M | 0.00 | 23.40M | |||
| Exchange Rate Effect | 68.39K | -710.00 | -64.90K | -97.10K | 40.00K | |||
| CHANGE IN CASH | 3.80M | 4.77M | -6.70M | -4.34M | 12.15M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -10.65M | -9.57M | -7.38M | -3.36M | -11.30M | |||
| Capital Expenditure | N/A | -5.37K | N/A | N/A | N/A | |||
| FREE CASH FLOW | -10.65M | -9.58M | -7.38M | -3.36M | -11.30M | |||
All data in USD